• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
KONG Xueli,HU Yingyue,SUN Yaru,YANG Haoxin,ZHANG Xuan.Preventive effects and mechanisms of Yanhuning on lipopolysaccharide-induced acute lung injury[J].Journal Of Pharmaceutical Research,2026,45(4):361-366,380[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2196times   Download 852次 QR Code for this article
Scan with your phone!
炎琥宁对脂多糖诱导急性肺损伤的防治作用及机制
孔学礼1,2,胡颖玥1,孙亚茹1,杨浩鑫1,张旋1
Font:Larger+|Default|Smaller-
(1.昆明医科大学药学院暨云南省天然药物药理重点实验室/云南省现代生物医药产业学院,云南 昆明 650500;2.云南省药品和医疗器械审评中心,云南 昆明 650101)
摘要:
目的 采用气管滴注脂多糖 (lipopolysaccharide,LPS)的方法构建小鼠急性肺损伤(acute lung injury, ALI)动物模型,研究注射用炎琥宁对急性肺损伤的防治作用及机制。方法 随机将小鼠分成6组,给药造模后采集小鼠的肺泡灌洗液(BALF)和肺组织标本。检测BALF中白细胞介素-6(IL-6)等6项炎症指标。对病理切片进行炎症评分。检测肺组织中丙二醛(MDA)和超氧化物歧化酶(SOD)。PCR检测Toll样受体4(TLR4)、含pyrin结构域NOD样受体家族3(NLRP3)、核因子κB(NF-κB)p65、c-Jun氨基端激酶(JNK)、细胞外调节蛋白激酶(Erk1/2)、p38对应mRNA表达水平。蛋白印迹法(Western blotting)测NLRP3、TLR4、NF-κB p65、JNK、Erk1/2、p38蛋白表达水平。结果 与LPS模型组比较,注射用炎琥宁能够改善ALI小鼠模型肺组织损伤程度,降低病理组织形态学炎症评分,减轻炎症反应;可提升ALI小鼠肺组织内的SOD活力,降低MDA含量;可以使ALI小鼠BALF中的总细胞数量、总蛋白浓度,细胞炎症因子IL-1β、IL-6、TNF-α的含量水平下降;TLR4、NLPR3、NF-κB p65和JNK、ErK1/2、p38蛋白及mRNA表达水平下调。结论 炎琥宁能减轻LPS诱导的ALI小鼠肺损伤程度,抑制肺部炎症反应,减轻氧化损伤,增强抗氧化能力。炎琥宁对ALI的防治作用机制与抑制TLR4/NF-κB和MAPK信号通路激活有关。
关键词:  注射用炎琥宁  急性肺损伤  丝裂原活化蛋白激酶  Toll样受体4/核因子κB  氧化应激
DOI:10.13506/j.cnki.jpr.2026.04.001
基金项目:国家自然科学基金项目(No.82260727);昆明医科大学科技创新团队项目(No.CXTD2022003)
Received Date:November 19, 2025   Revision Date:January 07, 2026   Publication Date:April 30, 2026
Preventive effects and mechanisms of Yanhuning on lipopolysaccharide-induced acute lung injury
KONG Xueli1,2,HU Yingyue1,SUN Yaru1,YANG Haoxin1,ZHANG Xuan1
(1.School of Pharmaceutical Science , Kunming Medical University and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming 650500, China; 2.Yunnan Provincial Center for Drug and Medical Device Evaluation, Kunming 650101, China)
Abstract:
Objective To establish a murine model of acute lung injury (ALI) via intratracheal instillation of lipopolysaccharide (LPS) and investigate the therapeutic/preventive effects and underlying mechanism of Yanhuning for Injection on ALI.Methods The mice were randomly divided into six groups, following drug administration and modeling, bronchoalveolar lavage fluid (BALF) and lung tissue specimens were collected from each group. Six inflammatory markers, including IL-1β, IL-6 and TNF-α,etc, were measured in the BALF. Histopathological sections were scored for inflammation. The content of MDA and the activity of SOD in the tissues were measured. RT-qPCR was used to detect the mRNA expression levels of TLR4, NLRP3, NF-κB p65, JNK, Erk1/2, and p38. Western blotting was employed to determine the protein expression levels of NLRP3, TLR4, NF-κB p65, JNK, Erk1/2 and p38.Results Compared to the LPS model group, Yanhuning for Injection ameliorated lung tissue damage, reduced histopathological inflammation scores, and attenuated the inflammatory response in the ALI mouse model. It significantly increased the SOD activity and decreased the MDA content in the model group. It also significantly reduced the total cell count, total protein concentration, and the levels of inflammatory cytokines IL-1β, IL-6, and TNF-α in the model group. The expression levels of TLR4, NLRP3, NF-κB p65, JNK, Erk1/2, p38 proteins, and their corresponding mRNAs were markedly downregulated.Conclusion Yanhuning can significantly alleviate the degree of lung injury in LPS-induced ALI mice, inhibit pulmonary inflammatory responses, reduce oxidative damage, and enhance antioxidant capacity. The mechanism of Yanhuning's preventive effects on ALI is related to the inhibition the activation of TLR4/NF-κB and MAPK signaling pathway.
Key words:  Yanhuning for Injection  Acute lung injury  MAPK  TLR4/NF-κB  Oxidative stress
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.